The startup is developing a personalized cognitive rehabilitation platform that utilizes neuroplasticity principles to enhance recovery for patients with neurodegenerative diseases. By digitally mapping brain responses, the company aims to create targeted therapeutic interventions that improve patient outcomes and accelerate the development of new treatments.
Funding
Funding not disclosed
Founders
Product
Problem
Patients with neurodegenerative diseases often face limited access to personalized and comprehensive cognitive rehabilitation programs. The lack of tailored therapeutic interventions can hinder recovery and slow the development of new treatments.
Solution
This startup is developing a personalized cognitive rehabilitation platform designed to enhance recovery for individuals with neurodegenerative diseases. By digitally mapping brain responses, the platform aims to create targeted therapeutic interventions based on neuroplasticity principles. The platform strives to provide accessible and comprehensive cognitive rehabilitation, potentially improving patient outcomes and accelerating the development of new treatments. The company's approach focuses on tailoring neurotechnology to individual brain health, offering a promising avenue for personalized solutions in neurological care. The platform aims to redefine neurorehabilitation through cognitive-explicit therapeutics, allowing individuals to begin cognitive rehabilitation anywhere and at any time.
Target Audience
The primary target audience includes patients with neurodegenerative diseases seeking personalized cognitive rehabilitation, as well as healthcare providers and researchers focused on neurological care and treatment development.
Features
- Digital mapping of brain responses to create personalized therapeutic interventions.
- Utilization of neuroplasticity principles to enhance cognitive recovery.
- Comprehensive platform accessible anywhere and at any time.